Aspire porcine bioprosthesis: Ten years' experience

Journal of Heart Valve Disease

Volumn 14, Issue 1, 2005, Pages 47-53

  Hadjinikolaou, Leonidas ^b   Boehm, Maria C ^b   Ganner, Catherine ^a   Kendall, Simon W ^c   Rosin, Michael D ^a   Goldsmith, Ira R ^a   Spyt, Tom J ^b  

^a WALSGRAVE HOSPITAL   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

AGED; AORTA VALVE REPLACEMENT; ARTICLE; BACTERIAL ENDOCARDITIS; BIOPROSTHESIS; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART PERFORMANCE; HEART VALVE REPLACEMENT; HUMAN; IMPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME; SWINE; THROMBOEMBOLISM; AGE; HEART VALVE PROSTHESIS; INFECTION; POSTOPERATIVE COMPLICATION; PROSTHESIS FAILURE; REOPERATION; STATISTICS; SURVIVAL; VALVULAR HEART DISEASE;

AGE FACTORS; AGED; BIOPROSTHESIS; ENDOCARDITIS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; SURVIVAL ANALYSIS; THROMBOEMBOLISM;

EID: 17944368005     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Goldsmith I, Mukundan S, Nugent A, Rosin MD. Early clinical experience with the Tissuemed porcine bioprosthesis. Ann Thorac Surg 1998;66(6 Suppl.):S259-S263
2. Goldsmith IR, Spyt TJ, Boehm M, Kendall S, Rosin MD. Midterm evaluation of the Tissuemed (Aspire) porcine bioprosthesis: 493 patients, 506 bioprostheses. Ann Thorac Surg 2001;71:1471-1476
3. Kumar P, Athanasiou T, Mussa S, Wood AJ. Ten year experience with Aspire (Tissuemed) porcine bioprosthesis: Single center experience. Cardiovasc Surg 2003;11:131-137
4. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-711
5. Jamieson WR, Burr LH, Tyers GF, et al. Carpentier-Edwards supra-annular porcine bioprosthesis: Clinical performance to twelve years. Ann Thorac Surg 1995;60(2 Suppl.):S235-S240
6. Pomar JL, Jamieson WR, Pelletier LC, Gerein AN, Castella M, Brownlee RT. Mitroflow pericardial bioprosthesis: Clinical performance to ten years. Ann Thorac Surg 1995;60(2 Suppl.):S305-S309
7. Cosgrove DM, Lytle BW, Taylor PC, et al. The Carpentier-Edwards pericardial aortic valve. Ten-year results. J Thorac Cardiovasc Surg 1995;110:651-662
8. Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H. Late haemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 2002;124:146-154
9. Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998;66(6 Suppl.):S57-S61
10. Pelletier LC, Carrier M, Leclerc Y, Dyrda I. The Carpentier-Edwards pericardial bioprosthesis: Clinical experience with 600 patients. Ann Thorac Surg 1995;60(2 Suppl.):S297-S302
11. Jamieson WR, Lemieux MD, Sullivan JA, Munro AI, Metras J, Cartier PC. Medtronic intact porcine bioprosthesis: 10 years' experience. Ann Thorac Surg 1998;66(6 Suppl.):S118-S121
12. Marchand MA, Aupart MR, Norton R, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001;71(5 Suppl.):S236-S239
13. Fremes SE, Goldman BS, Ivanov J, Weisel RD, David TE, Salerno T. Valvular surgery in the elderly. Circulation 1989;80(3 Pt.1):I77-I90
14. Kvidal P, Bergstrom R, Malm T, Stahle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J 2000;21:1099-1111
15. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747-756
16. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999;99:1851-1857
17. Ruel M, Rubens FD, Masters RG, et al. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves. J Thorac Cardiovasc Surg 2004;127:149-159
18. Raman JS, Ishikawa S, Power JM: Epicardial radiofrequency ablation of both atria in the treatment of atrial fibrillation: Experience in patients. Ann Thorac Surg 2002;74:1506-1509
19. Raman J, Ishikawa S, Storer MM, Power JM. Surgical radiofrequency ablation of both atria for atrial fibrillation: Results of a multicenter trial. J Thorac Cardiovasc Surg 2003;126:1357-1366
20. Blackstone EH, Cosgrove DM, Jamieson WR, et al. Prosthesis size and long-term survival after aortic valve replacement. J Thorac Cardiovasc Surg 2003;126:783-796
21. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17
22. Davila-Roman VG, Kouchoukos NT, Schechtman KB, Barzilai B. Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 1999;117:111-1116
23. Tunick PA, Kronzon I. Atheromas of the thoracic aorta: Clinical and therapeutic update. J Am Coll Cardiol 2000;35:545-554
24. Jamieson WR, Ling H, Burr LH, et al. Carpentier-Edwards supraannular porcine bioprosthesis evaluation over 15 years. Ann Thorac Surg 1998;66(6 Suppl.):S49-S52
25. Barratt-Boyes BG, Jaffe WM, Whitlock RM. The Medtronic Intact porcine valve: Ten-year clinical review. J Thorac Cardiovasc Surg 1998;116:1005-1014